WE DID IT!!
Thanks to collaborative and tenacious advocacy from the wound care community, the local coverage determinations (LCDs) and local coverage articles (LCAs) that would have dramatically restricted use and access to CTPs starting Oct. 1st have now been WITHDRAWN. 

SEE NEWS RELEASE

WARNING! EFFECTIVE OctoBER 1, 2023 MEDICARE WILL RESTRICT THE SKIN SUBSTITUTES AVAILABLE FOR YOUR DIABETIC FOOT OR VENOUS LEG ULCER

WE NEED YOUR HELP IN REQUESTING A DELAYED IMPLEMENTATION TO JANUARY 2024

What does this mean?
Effective October 1, 2023, Medicare has removed more than 100 CTP/"skin substitute" products from the list of products they will cover and pay for. In addition, Medicare will severely limit the number of skin substitute applications that can be used to a total of four in a 12-week period.

How does this affect me?
If you or a loved one are a patient with a Diabetic Foot Ulcer or Venous Leg Ulcer, your provider may not be able to use skin substitutes to manage your wound.

If you have just begun treatment with a non-covered skin substitute, your provider will need to stop on October 1, 2023 if:

• You have received 4 applications of a skin substitute
• Medicare decided that the skin substitute your provider is using is not covered

You may be asked to:

• Sign an ABN (Advanced Beneficiary Notice) that you will receive a service and or a product not covered by Medicare; and
• You will be responsible for payment to your provider for these VERY EXPENSIVE limb saving grafts.

Is there anything I can do?

YES! Please email your Medicare contractor using this sample letter.

See sample letter to send

There is a very small window of time to try to ensure that your care will not be disrupted.
Make your voice heard now! Submit an email by Monday, Sept. 25.

Download a PDF of this Patient Call To Action

Learn more: see issue overview
Questions? Email This email address is being protected from spambots. You need JavaScript enabled to view it.